Urosepsis after ureterorenoscopy, intraoperative recognition of type-IV stones could change clinical practice.


Journal

World journal of urology
ISSN: 1433-8726
Titre abrégé: World J Urol
Pays: Germany
ID NLM: 8307716

Informations de publication

Date de publication:
21 Sep 2024
Historique:
received: 04 11 2023
accepted: 28 08 2024
medline: 22 9 2024
pubmed: 22 9 2024
entrez: 21 9 2024
Statut: epublish

Résumé

Urosepsis currently accounts for half of all post flexible ureterorenoscopy (F-URS) complications, with an incidence of up to 4.3%. It represents a quarter of all septic episodes in adults and 2% of hospital spendings. The primary objective of this study was to define the predictive clinical parameters that increase the risk of urosepsis after F-URS. This prospective multicentric study evaluated patients who underwent F-URS for calculus between June 2016 and June 2018 in eleven French centers. Clinical, bacteriological, morpho-constitutional stone data, intraoperative information and complications were compared. Risk factors for postoperative urosepsis were identified and analyzed. We included 486 F-URS in 432 patients. The ureter was prepared using a double J stent in 51% of cases, a digital endoscope was used in 56% of patients with a median operative time of 120 min IQR (90-125) and using a sheath in 90% of cases. Postoperative urosepsis was observed in 18 patients (4%) with a median time to onset of 2 days IQR (1-5). The presence of coronary insufficiency: 3 (17%) vs 14 (3%) p = 0.005, a larger stone diameter: 11 cm [9-17] vs 10 cm [8-13] p = 0.02, a positive preoperative urine culture even when treated: 3 (17%) vs 56 (12%) p = 0.04, as well as the final composition of the type IV calculus (carbapatite or struvite) 5 (28%) vs 20 (4%) p < 0.001, were significantly associated with the occurrence of urosepsis. In multivariate analysis, only the presence of a type IV stone (OR = 14.0; p = 0.025) remained significant. Ureteroscopic treatment of a type IV stone (carbapatite or struvite) in a patient should raise concerns about the risk of post-operative urosepsis. When recognized intraoperatively, they should lead to a pyelic urinary sample and prolonged clinical surveillance.

Identifiants

pubmed: 39306607
doi: 10.1007/s00345-024-05251-3
pii: 10.1007/s00345-024-05251-3
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

534

Informations de copyright

© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Références

Wagenlehner FM et al (2013) Diagnosis and management for urosepsis: items in urosepsis. Int J Urol. https://doi.org/10.1111/iju.12200
doi: 10.1111/iju.12200 pubmed: 23714209
C. M. Torio and B. J. Moore, “National Inpatient Hospital Costs: The Most Expensive Conditions by Payer, 2013,” in Healthcare Cost and Utilization Project (HCUP) Statistical Briefs, Rockville (MD): Agency for Healthcare Research and Quality (US), 2006. Accessed: May 22, 2023. [Online]. http://www.ncbi.nlm.nih.gov/books/NBK368492/
De Coninck V et al (2020) Complications of ureteroscopy: a complete overview. World J Urol 38(9):2147–2166. https://doi.org/10.1007/s00345-019-03012-1
doi: 10.1007/s00345-019-03012-1 pubmed: 31748953
Somani BK et al (2017) Complications associated with ureterorenoscopy (URS) related to treatment of urolithiasis: the Clinical Research Office of Endourological Society URS Global study. World J Urol 35(4):675–681. https://doi.org/10.1007/s00345-016-1909-0
doi: 10.1007/s00345-016-1909-0 pubmed: 27492012
Haas CR, Li S, Knoedler MA, Penniston KL, Nakada SY (2023) Ureteroscopy and shock wave lithotripsy trends from 2012 to 2019 within the US medicare dataset: sharp growth in ureteroscopy utilization. J Endourol 37(2):219–224. https://doi.org/10.1089/end.2022.0402
doi: 10.1089/end.2022.0402 pubmed: 36205599
Bhojani N, Miller LE, Bhattacharyya S, Cutone B, Chew BH (2021) Risk factors for urosepsis after ureteroscopy for stone disease: a systematic review with meta-analysis. J Endourol 35(7):991–1000. https://doi.org/10.1089/end.2020.1133
doi: 10.1089/end.2020.1133 pubmed: 33544019
Singer M et al (2016) The third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA 315(8):801. https://doi.org/10.1001/jama.2016.0287
doi: 10.1001/jama.2016.0287 pubmed: 26903338 pmcid: 4968574
Corrales M, Doizi S, Barghouthy Y, Traxer O, Daudon M (2021) Classification of stones according to michel daudon: a narrative review. Eur Urol Focus 7(1):13–21. https://doi.org/10.1016/j.euf.2020.11.004
doi: 10.1016/j.euf.2020.11.004 pubmed: 33288482
Hesse A, Heimbach D (1999) Causes of phosphate stone formation and the importance of metaphylaxis by urinary acidification: a review. World J Urol 17(5):308–315. https://doi.org/10.1007/s003450050152
doi: 10.1007/s003450050152 pubmed: 10552150
Almeras C, Pradere B, Estrade V, Meria P, the Lithiasis Committee of the French Urological Association (2021) Endoscopic papillary abnormalities and stone recognition (EPSR) during flexible ureteroscopy: a comprehensive review. JCM 10(13):2888. https://doi.org/10.3390/jcm10132888
doi: 10.3390/jcm10132888 pubmed: 34209668 pmcid: 8267668
Keller EX et al (2019) Fragments and dust after Holmium laser lithotripsy with or without ‘Moses technology’: how are they different? J Biophotonics 12(4):e201800227. https://doi.org/10.1002/jbio.201800227
doi: 10.1002/jbio.201800227 pubmed: 30315636
Chabannes É et al (2013) Management of adult’s renal and ureteral stones. Update of the lithiasis committee of the French association of urology (CLAFU). General considerations. Prog Urol 23(16):1389–1399. https://doi.org/10.1016/j.purol.2013.08.315
doi: 10.1016/j.purol.2013.08.315 pubmed: 24274943
Michel Daudon, Olivier Traxer, Paul Jungers, Lithiase urinaire, 2e édition.
Chugh S, Pietropaolo A, Montanari E, Sarica K, Somani BK (2020) Predictors of urinary infections and urosepsis after ureteroscopy for stone disease: a systematic review from EAU section of urolithiasis (EULIS). Curr Urol Rep 21(4):16. https://doi.org/10.1007/s11934-020-0969-2
doi: 10.1007/s11934-020-0969-2 pubmed: 32211969
Randall JH et al (2023) On the rocks: can urologists identify stone composition based on endoscopic images alone? A worldwide survey of urologists. World J Urol 41(2):575–579. https://doi.org/10.1007/s00345-022-04269-9
doi: 10.1007/s00345-022-04269-9 pubmed: 36607392
Eswara JR, Sharif-Tabrizi A, Sacco D (2013) Positive stone culture is associated with a higher rate of sepsis after endourological procedures. Urolithiasis 41(5):411–414. https://doi.org/10.1007/s00240-013-0581-8
doi: 10.1007/s00240-013-0581-8 pubmed: 23760449
Nevo A, Mano R, Baniel J, Lifshitz DA (2017) Ureteric stent dwelling time: a risk factor for post-ureteroscopy sepsis. BJU Int 120(1):117–122. https://doi.org/10.1111/bju.13796
doi: 10.1111/bju.13796 pubmed: 28145037
Daudon M et al (2022) Urinary tract infection inducing stones: some clinical and chemical data. C R Chim 25(S1):315–334. https://doi.org/10.5802/crchim.159
doi: 10.5802/crchim.159
Çiftçioglu N, Björklund M, Kuorikoski K, Bergström K, Kajander EO (1999) Nanobacteria: an infectious cause for kidney stone formation. Kidney Int 56(5):1893–1898. https://doi.org/10.1046/j.1523-1755.1999.00755.x
doi: 10.1046/j.1523-1755.1999.00755.x pubmed: 10571799
Traxer O et al (2015) Differences in renal stone treatment and outcomes for patients treated either with or without the support of a ureteral access sheath: the clinical research office of the Endourological Society Ureteroscopy Global Study. World J Urol 33(12):2137–2144. https://doi.org/10.1007/s00345-015-1582-8
doi: 10.1007/s00345-015-1582-8 pubmed: 25971204 pmcid: 4655002
Pietropaolo A et al (2021) A machine learning predictive model for post-ureteroscopy urosepsis needing intensive care unit admission: a Case-Control YAU Endourology Study from Nine European Centres. J Clin Med 10(17):3888. https://doi.org/10.3390/jcm10173888
doi: 10.3390/jcm10173888 pubmed: 34501335 pmcid: 8432042
Jones P, Pietropaolo A, Chew BH, Somani BK (2021) Atlas of scoring systems, grading tools, and nomograms in endourology: a comprehensive overview from the TOWER Endourological Society Research Group. J Endourol 35(12):1863–1882. https://doi.org/10.1089/end.2021.0124
doi: 10.1089/end.2021.0124 pubmed: 33878937
Geraghty RM et al (2022) Post-ureteroscopy infections are linked to pre-operative stent dwell time over two months: outcomes of three European endourology centres. JCM 11(2):310. https://doi.org/10.3390/jcm11020310
doi: 10.3390/jcm11020310 pubmed: 35054005 pmcid: 8777996
Huang J-S, Xie J, Huang X-J, Yuan Q, Jiang H-T, Xiao K-F (2020) Flexible ureteroscopy and laser lithotripsy for renal stones 2 cm or greater: a single institutional experience. Medicine 99(43):e22704. https://doi.org/10.1097/MD.0000000000022704
doi: 10.1097/MD.0000000000022704 pubmed: 33120764 pmcid: 7581148
Vallée M et al (2019) Perioperative infectious risk in urology: Management of preoperative polymicrobial urine culture. A systematic review. By the infectious disease Committee of the French Association of urology. Prog Urol 29(5):253–262. https://doi.org/10.1016/j.purol.2019.02.010
doi: 10.1016/j.purol.2019.02.010 pubmed: 30962140

Auteurs

Maxime Pattou (M)

Louis University Hospital, Paris, France. maxime.pattou@gmail.com.

Laurent Yonneau (L)

Foch University Hospital, Suresnes, France.

Amaury de Gouvello (A)

Louis University Hospital, Paris, France.

Christophe Almeras (C)

Croix du Sud Private Hospital, Quint-Fonsegrives, France.

Christian Saussine (C)

Joseph University Hospital, Lyon, France.

Andras Hoznek (A)

Mondor University Hospital, Créteil, France.

Etienne Denis (E)

Edouard Herriot University Hospital, Lyon, France.

Eric Chabannes (E)

Besançon University Hospital, Besançon, France.

Eric Lechevallier (E)

Marseille University Hospital, Marseille, France.

Nadia Abid (N)

Strasbourg University Hospital, Strasbourg, France.

Jacques Hubert (J)

Nancy-Brabois University Hospital, Vandœuvre-Lès-Nancy, France.

Vincent Estrade (V)

Bordeaux University Hospital, Bordeaux, France.

Paul Meria (P)

Louis University Hospital, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH